Fig 1: Soluble IFNAR2 (sIFNAR2) plasma levels of severe COVID-19 patients (n = 347) divided into non-survivor (n = 108, yellow dots) and survivor (n = 239, purple dots). sIFNAR2 level was evaluated by ELISA. Statistical comparison was performed using Mann-Whitney U Test, p < 0.05.
Fig 2: Soluble IFNAR2 (sIFNAR2) plasma levels of severe COVID-19 patients (n = 347) divided according to the comorbidity systemic arterial hypertension (SAH) (Yes: n = 121, yellow dots; No: n = 226, purple dots). sIFNAR2 level was evaluated by ELISA. Statistical comparison was performed using Mann-Whitney U Test, p < 0.01.
Supplier Page from Thermo Fisher Scientific for Human IFN alpha/beta R2 ELISA Kit